Y. V. Skrypko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Y. V. Skrypko has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- O. L. Tkachuk
Івано-Франківський національний медичний університет
2 shared publications - V. D. Skripko
Івано-Франківський національний медичний університет
1 shared publication - V. D. Skrypko
Ivano-Frankivsk National Medical University
1 shared publication
Latest Publications
- Open Access
- 9 November 2026
- Published by Publishing House Helvetica (Publications) in Науковий вісник Ужгородського університету. Серія Медицина
- No. 2(74),p. 55-62
Оцінка ефективності алгоритму персоналізованого вибору обсягу хірургічного втручання при папілярній мікрокарциномі щитоподібної залози на основі визначення імуноцитохімічних маркерів агресивності
Папілярна мікрокарцинома щитоподібної залози (ПМЩЗ) є найпоширенішою формою тиреоїдних злоякісних новоутворень і в більшості випадків характеризується сприятливим клінічним перебігом. Разом з тим певна частка ПМЩЗ виявляє ознаки біологічної агресивності: екстратиреоїдну інвазію, регіонарне лімфогенне метастазування та схильність до рецидиву. Чинні міжнародні настанови ATA (2025) та NCCN (2025) орієнтують хірургічну спільноту на скорочення обсягу хірургічних втручань у пацієнтів із низьким ризиком агресивності, однак практичне втілення цього підходу неможливе без достовірних інструментів доопераційної оцінки агресивності пухлини. Одним із перспективних напрямків є інтеграція імуноцитохімічних маркерів у клінічні алгоритми прийняття хірургічних рішень на підставі цитологічного матеріалу ТАПБ. Мета дослідження. Оцінити клінічну ефективність алгоритму персоналізованого вибору обсягу хірургічного втручання при ПМЩЗ, який інтегрує результати доопераційного визначення ЦК17, ТПО та S-клітин у процес прийняття хірургічного рішення. Матеріали і методи. Виконано проспективне відкрите порівняльне дослідження за участю 110 хворих із цитологічно підтвердженою ПМЩЗ (≤10 мм; Bethesda V-VI), які отримували лікування в КНП «Прикарпатський клінічний онкологічний центр» у 2024–2026 рр. Контрольну групу (n=54) склали пацієнти, у яких обсяг хірургічного втручання обирали на підставі стандартних клінічних, ультрасонографічних та цитологічних критеріїв. В основній групі (n=56) додатково проводили доопераційне імуноцито- хімічне дослідження з визначенням ЦК17, тиреоїдної пероксидази (ТПО) та S-клітин із наступною стратифікацією ризику агресивності. Аналізували структуру хірургічних втручань, частоту виявлення регіонарних метастазів, частоту та характер ускладнень за Clavien–Dindo, прогностичну точність моделі (ROC-аналіз, AUC) та відповідність доопераційного прогнозу даним патоморфологічного дослідження (κ Коена). Результати. В основній групі питома вага органозберігаючих операцій (гемітиреоїдектомій) була статистично достовірно вищою, ніж у контрольній (60,7% проти 33,3%; p=0,006). Загальна частота післяопераційних ускладнень виявилася нижчою (30,4% проти 50,0%; OR=0,42; 95% ДІ: 0,19–0,92; p=0,037). Частота виявлення регіонарного метастазування була вищою в основній групі (53,6% проти 31,5%; p=0,019), що свідчило про покращення доопераційної ідентифікації пацієнтів із високим ризиком лімфогенного поширення пухлини. Розроблений алгоритм стратифікації ризику на основі ІЦХ-панелі (ЦК17, ТПО та S-клітини) продемонстрував відмінну прогностичну ефективність: AUC=0,91 (95% ДІ: 0,84–0,97), загальну точність 85,5% та коефіцієнт узгодженості κ Коена 0,77 (p<0,001). Висновки. Розроблений алгоритм, що поєднує клінічні, ультрасонографічні, цитологічні та імуноцитохімічні критерії агресивності, дозволяє обґрунтовано персоналізувати обсяг хірургічного лікування ПМЩЗ. Його застосування супроводжується збільшенням частки органозберігаючих втручань, зменшенням частоти післяопераційних ускладнень та високою точністю прогнозування агресивного перебігу захворювання. Отримані результати свідчать про перспективність впровадження алгоритму в рутинну клінічну практику
- 9 November 2026
- Published by Publishing House Helvetica (Publications) in Науковий вісник Ужгородського університету. Серія Медицина
- No. 2(74),p. 55-62
Open AccessОцінка ефективності алгоритму персоналізованого вибору обсягу хірургічного втручання при папілярній мікрокарциномі щитоподібної залози на основі визначення імуноцитохімічних маркерів агресивності
Папілярна мікрокарцинома щитоподібної залози (ПМЩЗ) є найпоширенішою формою тиреоїдних злоякісних новоутворень і в більшості випадків характеризується сприятливим клінічним перебігом. Разом з тим певна частка ПМЩЗ виявляє ознаки біологічної агресивності: екстратиреоїдну інвазію, регіонарне лімфогенне метастазування та схильність до рецидиву. Чинні міжнародні настанови ATA (2025) та NCCN (2025) орієнтують хірургічну спільноту на скорочення обсягу хірургічних втручань у пацієнтів із низьким ризиком агресивності, однак практичне втілення цього підходу неможливе без достовірних інструментів доопераційної оцінки агресивності пухлини. Одним із перспективних напрямків є інтеграція імуноцитохімічних маркерів у клінічні алгоритми прийняття хірургічних рішень на підставі цитологічного матеріалу ТАПБ. Мета дослідження. Оцінити клінічну ефективність алгоритму персоналізованого вибору обсягу хірургічного втручання при ПМЩЗ, який інтегрує результати доопераційного визначення ЦК17, ТПО та S-клітин у процес прийняття хірургічного рішення. Матеріали і методи. Виконано проспективне відкрите порівняльне дослідження за участю 110 хворих із цитологічно підтвердженою ПМЩЗ (≤10 мм; Bethesda V-VI), які отримували лікування в КНП «Прикарпатський клінічний онкологічний центр» у 2024–2026 рр. Контрольну групу (n=54) склали пацієнти, у яких обсяг хірургічного втручання обирали на підставі стандартних клінічних, ультрасонографічних та цитологічних критеріїв. В основній групі (n=56) додатково проводили доопераційне імуноцито- хімічне дослідження з визначенням ЦК17, тиреоїдної пероксидази (ТПО) та S-клітин із наступною стратифікацією ризику агресивності. Аналізували структуру хірургічних втручань, частоту виявлення регіонарних метастазів, частоту та характер ускладнень за Clavien–Dindo, прогностичну точність моделі (ROC-аналіз, AUC) та відповідність доопераційного прогнозу даним патоморфологічного дослідження (κ Коена). Результати. В основній групі питома вага органозберігаючих операцій (гемітиреоїдектомій) була статистично достовірно вищою, ніж у контрольній (60,7% проти 33,3%; p=0,006). Загальна частота післяопераційних ускладнень виявилася нижчою (30,4% проти 50,0%; OR=0,42; 95% ДІ: 0,19–0,92; p=0,037). Частота виявлення регіонарного метастазування була вищою в основній групі (53,6% проти 31,5%; p=0,019), що свідчило про покращення доопераційної ідентифікації пацієнтів із високим ризиком лімфогенного поширення пухлини. Розроблений алгоритм стратифікації ризику на основі ІЦХ-панелі (ЦК17, ТПО та S-клітини) продемонстрував відмінну прогностичну ефективність: AUC=0,91 (95% ДІ: 0,84–0,97), загальну точність 85,5% та коефіцієнт узгодженості κ Коена 0,77 (p<0,001). Висновки. Розроблений алгоритм, що поєднує клінічні, ультрасонографічні, цитологічні та імуноцитохімічні критерії агресивності, дозволяє обґрунтовано персоналізувати обсяг хірургічного лікування ПМЩЗ. Його застосування супроводжується збільшенням частки органозберігаючих втручань, зменшенням частоти післяопераційних ускладнень та високою точністю прогнозування агресивного перебігу захворювання. Отримані результати свідчать про перспективність впровадження алгоритму в рутинну клінічну практику
- Open Access
- 30 September 2026
- Published by Publishing Company VIT-A-POL in Clinical endocrinology and endocrine surgery
- No. 3,p. 53-60
Personalization of the extent of surgical treatment for papillary thyroid carcinoma based on preoperative immunocytochemical risk stratification
Papillary thyroid microcarcinoma (PTMC) is the most commonly diagnosed form of thyroid cancer and generally has a favorable prognosis. However, a subset of PTMCs exhibits an aggressive biological course characterized by extrathyroidal extension, regional lymph node metastasis, and recurrence. Current recommendations of the American Thyroid Association (ATA) and the National Comprehensive Cancer Network (NCCN) (2024) support less extensive surgical treatment, when indicated, in patients at low risk; however, implementation of this approach requires reliable methods for preoperative stratification of tumor aggressiveness. Immunocytochemical markers may provide a promising approach for predicting the biological behavior of PTMC at the preoperative stage. Objective — to evaluate the effectiveness of a combined preoperative panel of immunocytochemical markers (cytokeratin 17, thyroid peroxidase, and S-cells) for risk stratification of aggressive papillary thyroid microcarcinoma and personalization of the extent of surgical treatment. Materials and methods. A prospective comparative study was conducted in 110 patients with cytologically verified PTMC (Ј 10 mm) who were treated at the Precarpathian Clinical Oncology Center in 2024 — 2026. The control group included 54 patients whose extent of surgery was determined according to standard clinical, ultrasonographic, and cytological criteria. The study group comprised 56 patients who additionally underwent preoperative immunocytochemical assessment of cytokeratin 17 (CK17), thyroid peroxidase (TPO), and S-cells, followed by risk stratification. The extent of surgical intervention, frequency of regional metastasis, postoperative complications, predictive performance of the model [ROC analysis and area under the ROC curve (AUC)], and concordance between the preoperative prediction and histopathological findings (Cohen’s k) were assessed. Results. In the study group, the proportion of organ-sparing procedures was significantly higher than in the control group (60.7% vs. 33.3%, p=0.004), while the overall rate of postoperative complications was lower (30.4% vs. 50.0%; odds ratio, 0.44; 95% confidence interval, 0.20 — 0.95; p=0.036). The detection rate of regional metastases was higher in the study group (53.6% vs. 31.5%, p=0.019), which was associated with more targeted selection of patients for extended surgical staging. The combined model (CK17, TPO, and S-cells) demonstrated high predictive performance, with an area under the ROC curve of 0.91 (95% confidence interval, 0.84 — 0.97), an overall accuracy of 85.5%, and substantial agreement with histopathological findings (k=0.77; p<0.001). Conclusions. Preoperative stratification of PTMC aggressiveness using a combined panel of CK17, TPO, and S-cells may enable personalization of the extent of surgical treatment. In the study group, the proportion of justified organ-sparing procedures was higher, while the overall rate of postoperative complications was lower than in the control group. Regional metastases were detected more frequently in the study group; this finding may have been influenced by the extent of lymph node dissection. The combined model demonstrated high predictive performance (AUC=0.91) and may be considered a promising tool for preoperative risk stratification in patients with PTMC.
- 30 September 2026
- Published by Publishing Company VIT-A-POL in Clinical endocrinology and endocrine surgery
- No. 3,p. 53-60
Open AccessPersonalization of the extent of surgical treatment for papillary thyroid carcinoma based on preoperative immunocytochemical risk stratification
Papillary thyroid microcarcinoma (PTMC) is the most commonly diagnosed form of thyroid cancer and generally has a favorable prognosis. However, a subset of PTMCs exhibits an aggressive biological course characterized by extrathyroidal extension, regional lymph node metastasis, and recurrence. Current recommendations of the American Thyroid Association (ATA) and the National Comprehensive Cancer Network (NCCN) (2024) support less extensive surgical treatment, when indicated, in patients at low risk; however, implementation of this approach requires reliable methods for preoperative stratification of tumor aggressiveness. Immunocytochemical markers may provide a promising approach for predicting the biological behavior of PTMC at the preoperative stage. Objective — to evaluate the effectiveness of a combined preoperative panel of immunocytochemical markers (cytokeratin 17, thyroid peroxidase, and S-cells) for risk stratification of aggressive papillary thyroid microcarcinoma and personalization of the extent of surgical treatment. Materials and methods. A prospective comparative study was conducted in 110 patients with cytologically verified PTMC (Ј 10 mm) who were treated at the Precarpathian Clinical Oncology Center in 2024 — 2026. The control group included 54 patients whose extent of surgery was determined according to standard clinical, ultrasonographic, and cytological criteria. The study group comprised 56 patients who additionally underwent preoperative immunocytochemical assessment of cytokeratin 17 (CK17), thyroid peroxidase (TPO), and S-cells, followed by risk stratification. The extent of surgical intervention, frequency of regional metastasis, postoperative complications, predictive performance of the model [ROC analysis and area under the ROC curve (AUC)], and concordance between the preoperative prediction and histopathological findings (Cohen’s k) were assessed. Results. In the study group, the proportion of organ-sparing procedures was significantly higher than in the control group (60.7% vs. 33.3%, p=0.004), while the overall rate of postoperative complications was lower (30.4% vs. 50.0%; odds ratio, 0.44; 95% confidence interval, 0.20 — 0.95; p=0.036). The detection rate of regional metastases was higher in the study group (53.6% vs. 31.5%, p=0.019), which was associated with more targeted selection of patients for extended surgical staging. The combined model (CK17, TPO, and S-cells) demonstrated high predictive performance, with an area under the ROC curve of 0.91 (95% confidence interval, 0.84 — 0.97), an overall accuracy of 85.5%, and substantial agreement with histopathological findings (k=0.77; p<0.001). Conclusions. Preoperative stratification of PTMC aggressiveness using a combined panel of CK17, TPO, and S-cells may enable personalization of the extent of surgical treatment. In the study group, the proportion of justified organ-sparing procedures was higher, while the overall rate of postoperative complications was lower than in the control group. Regional metastases were detected more frequently in the study group; this finding may have been influenced by the extent of lymph node dissection. The combined model demonstrated high predictive performance (AUC=0.91) and may be considered a promising tool for preoperative risk stratification in patients with PTMC.
- Open Access
- 30 September 2026
- Published by Ternopil State Medical University in Шпитальна хірургія. Журнал імені Л. Я. Ковальчука
- No. 3,p. 28-33
Вплив персоналізованого вибору обсягу хірургічного втручання на ранні післяопераційні результати та якість життя пацієнтів із папілярною мікрокарциномою щитоподібної залози
The aim of the work: to assess the association between personalized selection of surgical intervention extent for papillary thyroid microcarcinoma with early postoperative complications and health-related quality of life. Materials and Methods. A secondary analysis of a prospectively assembled comparative cohort of 110 patients treated in 2024–2026 was performed. In the control group (n=54), surgical extent was selected using standard clinical, ultrasonographic, and cytological criteria. In the study group (n=56), preoperative immunocytochemical assessment of cytokeratin 17, thyroid peroxidase, and S-cells was additionally incorporated into comprehensive risk stratification. Complications were graded according to the Clavien-Dindo classification. Quality of life was assessed with the SF-36 at 3 months after surgery in all 110 patients according to the actual procedure: hemithyroidectomy (n=52) or thyroidectomy (n=58). Results. Hemithyroidectomy was more frequent in the study group than in the control group (60.7 % vs 33.3 %; p=0.004). The overall early complication rate was lower (30.4 % vs 50.0 %; OR=0.44; 95 % CI=0.20–0.95; p=0.036). Major complications (Clavien-Dindo III–IV) were numerically less frequent but did not reach statistical significance (1.8 % vs 9.3 %; p=0.110). After hemithyroidectomy, scores were higher for physical functioning (84.2±9.1 vs 72.5±10.4), role-physical functioning (81.5±10.3 vs 69.7±11.2), vitality (78.6±8.7 vs 67.4±9.5), and social functioning (86.3±7.5 vs 74.8±8.9); all eight SF-36 domains differed at p<0.001. The findings indicate more favorable short-term patient-oriented outcomes after less extensive surgery; however, because of the nonrandomized design, these differences should be interpreted as associations rather than causal effects. Conclusions. Personalized selection of surgical extent was associated with more frequent hemithyroidectomy, a lower overall early complication rate, and better quality-of-life scores 3 months after organ-preserving surgery.
- 30 September 2026
- Published by Ternopil State Medical University in Шпитальна хірургія. Журнал імені Л. Я. Ковальчука
- No. 3,p. 28-33
Open AccessВплив персоналізованого вибору обсягу хірургічного втручання на ранні післяопераційні результати та якість життя пацієнтів із папілярною мікрокарциномою щитоподібної залози
The aim of the work: to assess the association between personalized selection of surgical intervention extent for papillary thyroid microcarcinoma with early postoperative complications and health-related quality of life. Materials and Methods. A secondary analysis of a prospectively assembled comparative cohort of 110 patients treated in 2024–2026 was performed. In the control group (n=54), surgical extent was selected using standard clinical, ultrasonographic, and cytological criteria. In the study group (n=56), preoperative immunocytochemical assessment of cytokeratin 17, thyroid peroxidase, and S-cells was additionally incorporated into comprehensive risk stratification. Complications were graded according to the Clavien-Dindo classification. Quality of life was assessed with the SF-36 at 3 months after surgery in all 110 patients according to the actual procedure: hemithyroidectomy (n=52) or thyroidectomy (n=58). Results. Hemithyroidectomy was more frequent in the study group than in the control group (60.7 % vs 33.3 %; p=0.004). The overall early complication rate was lower (30.4 % vs 50.0 %; OR=0.44; 95 % CI=0.20–0.95; p=0.036). Major complications (Clavien-Dindo III–IV) were numerically less frequent but did not reach statistical significance (1.8 % vs 9.3 %; p=0.110). After hemithyroidectomy, scores were higher for physical functioning (84.2±9.1 vs 72.5±10.4), role-physical functioning (81.5±10.3 vs 69.7±11.2), vitality (78.6±8.7 vs 67.4±9.5), and social functioning (86.3±7.5 vs 74.8±8.9); all eight SF-36 domains differed at p<0.001. The findings indicate more favorable short-term patient-oriented outcomes after less extensive surgery; however, because of the nonrandomized design, these differences should be interpreted as associations rather than causal effects. Conclusions. Personalized selection of surgical extent was associated with more frequent hemithyroidectomy, a lower overall early complication rate, and better quality-of-life scores 3 months after organ-preserving surgery.
- Open Access
- 11 March 2026
- Published by Ivano-Frankivsk National Medical University in Archive of Clinical Medicine
- Vol. 32 (1) , 38-41
Individualized selection of surgical strategy for thyroid microcarcinoma: clinical and cytological criteria for decision-making
Introduction. Papіllary thyroіd mіcrocarcіnoma (PTMC) іs the most common form of dіfferentіated thyroіd cancer and usually has a favorable prognosіs; however, іn 8-15% of cases іt demonstrates features of aggressіveness [1, 2]. The bіologіcal behavіor of the tumor іs determіned not only by іts sіze but also by clіnіcal and іnstrumental characterіstіcs that reflect іnvasіve potentіal and the rіsk of regіonal metastasіs [2, 3]. Key predіctors of an aggressіve course іnclude young age, male sex, hypoechogenіcіty, іll-defіned margіns, the presence of mіcrocalcіfіcatіons, as well as changes іn the expressіon of іmmunocytochemіcal markers-cytokeratіn-17 (CK17) and thyroіd peroxіdase (TPO) [2-4, 7-9]. Іncreased CK17 expressіon and decreased TPO expressіon correlate wіth a lower degree of tumor dіfferentіatіon and a more aggressіve clіnіcal behavіor [4-6]. Accordіng to the recommendatіons of the Amerіcan Thyroіd Assocіatіon (ATA, 2015), takіng іnto account later offіcіal posіtіon statements, consensus documents and clіnіcal updates of the ATA, as well as the current recommendatіons of the Natіonal Comprehensіve Cancer Network (NCCN 2024-2025), hemіthyroіdectomy may be a suffіcіent radіcal іnterventіon іn the absence of sіgns of aggressіveness, whіch underscores the need for comprehensіve preoperatіve rіsk stratіfіcatіon of patіents [3, 4, 7]. Aіm. To perform a comprehensіve assessment of papіllary thyroіd mіcrocarcіnoma characterіstіcs, іn partіcular the expressіon of CK17 and thyroіd peroxіdase (TPO) іn tumor aspіrates, іn order to determіne the prognostіc value of these markers when selectіng surgіcal treatment tactіcs. Materіals and methods. The study was conducted at the Munіcіpal Nonprofіt Enterprіse «Precarpathian Clinical Oncology Centre» (2024-2025) and іncluded 58 patіents wіth cytologіcally confіrmed PTMC (sіze ≤10 mm). Clіnіcal, ultrasound, laboratory, and іmmunocytochemіcal testіng for CK17 and TPO was performed. Patіents were stratіfіed іnto two groups accordіng to features of potentіal aggressіveness. Results. Sіgns of an aggressіve course were detected іn 21 patіents (36.2%), who were assіgned to the hіgh-rіsk group A; these іncluded cases wіth mіcrovascular іnvasіon, extrathyroіdal extensіon, and/or lymphogenous metastasіs. Іn thіs group, hіgh CK17 expressіon (≥10%) and reduced TPO expressіon (<25%) were sіgnіfіcantly more frequent, reflectіng a lower degree of tumor dіfferentіatіon and hіgher іnvasіve potentіal (p<0.05). Іn 37 patіents (63.8%) assіgned to group B, no sіgns of aggressіveness were detected; the dіsease was characterіzed by favorable clіnіcal and ultrasound features and a preserved іmmunocytochemіcal profіle. The combіnatіon of clіnіcal, ultrasound, and іmmunocytochemіcal crіterіa ensured a justіfіed choіce of the extent of surgery and made іt possіble to avoіd overtreatment, іn partіcular unjustіfіed extensіon of surgіcal іnterventіon іn patіents of group B. Conclusіons. Іmmunocytochemіcal markers CK17 and TPO are іnformatіve predіctors of an aggressіve course of PTMC and іncrease the accuracy of preoperatіve prognosіs. The use of personalіzed surgіcal tactіcs wіth determіnatіon of CK17 and TPO reduces the rіsk of an excessіve extent of surgіcal іnterventіon. Іn addіtіon, іn patіents of group B after hemіthyroіdectomy there іs no need for suppressіve therapy, and іn some patіents for replacement therapy, whіch provіdes a pronounced economіc and socіal effect (reductіon of costs for medіcatіons, laboratory monіtorіng, and іmprovement of qualіty of lіfe).
- 11 March 2026
- Published by Ivano-Frankivsk National Medical University in Archive of Clinical Medicine
- Vol. 32 (1) , 38-41
Open AccessIndividualized selection of surgical strategy for thyroid microcarcinoma: clinical and cytological criteria for decision-making
Introduction. Papіllary thyroіd mіcrocarcіnoma (PTMC) іs the most common form of dіfferentіated thyroіd cancer and usually has a favorable prognosіs; however, іn 8-15% of cases іt demonstrates features of aggressіveness [1, 2]. The bіologіcal behavіor of the tumor іs determіned not only by іts sіze but also by clіnіcal and іnstrumental characterіstіcs that reflect іnvasіve potentіal and the rіsk of regіonal metastasіs [2, 3]. Key predіctors of an aggressіve course іnclude young age, male sex, hypoechogenіcіty, іll-defіned margіns, the presence of mіcrocalcіfіcatіons, as well as changes іn the expressіon of іmmunocytochemіcal markers-cytokeratіn-17 (CK17) and thyroіd peroxіdase (TPO) [2-4, 7-9]. Іncreased CK17 expressіon and decreased TPO expressіon correlate wіth a lower degree of tumor dіfferentіatіon and a more aggressіve clіnіcal behavіor [4-6]. Accordіng to the recommendatіons of the Amerіcan Thyroіd Assocіatіon (ATA, 2015), takіng іnto account later offіcіal posіtіon statements, consensus documents and clіnіcal updates of the ATA, as well as the current recommendatіons of the Natіonal Comprehensіve Cancer Network (NCCN 2024-2025), hemіthyroіdectomy may be a suffіcіent radіcal іnterventіon іn the absence of sіgns of aggressіveness, whіch underscores the need for comprehensіve preoperatіve rіsk stratіfіcatіon of patіents [3, 4, 7]. Aіm. To perform a comprehensіve assessment of papіllary thyroіd mіcrocarcіnoma characterіstіcs, іn partіcular the expressіon of CK17 and thyroіd peroxіdase (TPO) іn tumor aspіrates, іn order to determіne the prognostіc value of these markers when selectіng surgіcal treatment tactіcs. Materіals and methods. The study was conducted at the Munіcіpal Nonprofіt Enterprіse «Precarpathian Clinical Oncology Centre» (2024-2025) and іncluded 58 patіents wіth cytologіcally confіrmed PTMC (sіze ≤10 mm). Clіnіcal, ultrasound, laboratory, and іmmunocytochemіcal testіng for CK17 and TPO was performed. Patіents were stratіfіed іnto two groups accordіng to features of potentіal aggressіveness. Results. Sіgns of an aggressіve course were detected іn 21 patіents (36.2%), who were assіgned to the hіgh-rіsk group A; these іncluded cases wіth mіcrovascular іnvasіon, extrathyroіdal extensіon, and/or lymphogenous metastasіs. Іn thіs group, hіgh CK17 expressіon (≥10%) and reduced TPO expressіon (<25%) were sіgnіfіcantly more frequent, reflectіng a lower degree of tumor dіfferentіatіon and hіgher іnvasіve potentіal (p<0.05). Іn 37 patіents (63.8%) assіgned to group B, no sіgns of aggressіveness were detected; the dіsease was characterіzed by favorable clіnіcal and ultrasound features and a preserved іmmunocytochemіcal profіle. The combіnatіon of clіnіcal, ultrasound, and іmmunocytochemіcal crіterіa ensured a justіfіed choіce of the extent of surgery and made іt possіble to avoіd overtreatment, іn partіcular unjustіfіed extensіon of surgіcal іnterventіon іn patіents of group B. Conclusіons. Іmmunocytochemіcal markers CK17 and TPO are іnformatіve predіctors of an aggressіve course of PTMC and іncrease the accuracy of preoperatіve prognosіs. The use of personalіzed surgіcal tactіcs wіth determіnatіon of CK17 and TPO reduces the rіsk of an excessіve extent of surgіcal іnterventіon. Іn addіtіon, іn patіents of group B after hemіthyroіdectomy there іs no need for suppressіve therapy, and іn some patіents for replacement therapy, whіch provіdes a pronounced economіc and socіal effect (reductіon of costs for medіcatіons, laboratory monіtorіng, and іmprovement of qualіty of lіfe).
- Open Access
- 30 June 2025
- Published by Publishing Company VIT-A-POL in Clinical endocrinology and endocrine surgery
- No. 2,p. 37-41
Experience of using certain immunocytochemical markers in preoperative prognostication of aggressiveness in highly differentiated thyroid tumors
Objective — to improve treatment outcomes for patients with highly differentiated papillary thyroid microcarcinoma (PTMC) by developing a differentiated surgical approach based on the preoperative assessment of cytokeratin-17 (CK17) and thyroid peroxidase (TPO) expression levels in fine-needle aspiration (FNA) samples of the thyroid gland. Materials and methods. The study included 31 patients with cytologically confirmed PTMC (≤ 10 mm) without signs of autoimmune thyroiditis or metastases. All patients underwent immunocytochemical analysis of thyroid FNA samples to evaluate CK17 and TPO expression levels. Based on the results, patients were stratified into two groups: those with an aggressive tumor phenotype (CK17 ≥ 10%, TPO <25%) and those with a non-aggressive phenotype. Accordingly, patients underwent either total thyroidectomy with lymph node dissection or hemithyroidectomy. Results. In 7 (22.6%) patients, an aggressive immunocytochemical profile was established, which correlated with the detection of follicular-infiltrative or diffuse sclerotic variant of MVP according to histological analysis. The remaining patients were diagnosed with non-aggressive morphological variants (classical, varicose). No recurrence or progression of the disease was recorded during follow-up. A statistically significant (p<0.05) association between high expression of CK-17, decreased TPO levels and aggressive course of MVP was established. Conclusions. Immunocytochemical assessment of the expression of CC-17 and TPO is informative for stratifying the risk of MVP aggressiveness at the preoperative stage. The use of these markers makes it possible to individualise the scope of surgical intervention in accordance with the biological behaviour of the tumour, which is consistent with current recommendations (ATA 2023, NCCN 2024, WHO 2022).
- 30 June 2025
- Published by Publishing Company VIT-A-POL in Clinical endocrinology and endocrine surgery
- No. 2,p. 37-41
Open AccessExperience of using certain immunocytochemical markers in preoperative prognostication of aggressiveness in highly differentiated thyroid tumors
Objective — to improve treatment outcomes for patients with highly differentiated papillary thyroid microcarcinoma (PTMC) by developing a differentiated surgical approach based on the preoperative assessment of cytokeratin-17 (CK17) and thyroid peroxidase (TPO) expression levels in fine-needle aspiration (FNA) samples of the thyroid gland. Materials and methods. The study included 31 patients with cytologically confirmed PTMC (≤ 10 mm) without signs of autoimmune thyroiditis or metastases. All patients underwent immunocytochemical analysis of thyroid FNA samples to evaluate CK17 and TPO expression levels. Based on the results, patients were stratified into two groups: those with an aggressive tumor phenotype (CK17 ≥ 10%, TPO <25%) and those with a non-aggressive phenotype. Accordingly, patients underwent either total thyroidectomy with lymph node dissection or hemithyroidectomy. Results. In 7 (22.6%) patients, an aggressive immunocytochemical profile was established, which correlated with the detection of follicular-infiltrative or diffuse sclerotic variant of MVP according to histological analysis. The remaining patients were diagnosed with non-aggressive morphological variants (classical, varicose). No recurrence or progression of the disease was recorded during follow-up. A statistically significant (p<0.05) association between high expression of CK-17, decreased TPO levels and aggressive course of MVP was established. Conclusions. Immunocytochemical assessment of the expression of CC-17 and TPO is informative for stratifying the risk of MVP aggressiveness at the preoperative stage. The use of these markers makes it possible to individualise the scope of surgical intervention in accordance with the biological behaviour of the tumour, which is consistent with current recommendations (ATA 2023, NCCN 2024, WHO 2022).